No data to show
XSTO
QCORE
Market cap372kUSD
Oct 08, Last price
0.44SEK
1D
-1.33%
1Q
-30.63%
IPO
-99.12%
Name
Qlucore AB (publ)
Chart & Performance
P/E
—
P/S
0.34
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.40%
Rev. gr., 5y
-8.63%
Revenues
10m
-28.96%
Net income
-21m
L+30.95%
CFO
-14m
L-16.49%
Profile
Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Diagnostics, a software platform for multi-omics companion and precision diagnostics; and Qlucore Insights, a software for clinical data analysis. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑04 | 2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2019‑04 | |
| Income | |||||||
Revenues | 10,208 -28.96% | 14,369 13.39% | 12,672 -10.24% | ||||
Cost of revenue | 19,957 | 6,971 | 10,309 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (9,749) | 7,398 | 2,363 | ||||
NOPBT Margin | 51.49% | 18.65% | |||||
Operating Taxes | 24 | 27 | 35 | ||||
Tax Rate | 0.36% | 1.48% | |||||
NOPAT | (9,773) | 7,371 | 2,328 | ||||
Net income | (20,535) 30.95% | (15,681) -1.60% | (15,936) 36.64% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 67 | ||||||
BB yield | -0.12% | ||||||
| Debt | |||||||
Debt current | 600 | (251) | 1,275 | ||||
Long-term debt | 1,400 | 2,000 | 3,183 | ||||
Deferred revenue | |||||||
Other long-term liabilities | (3,183) | ||||||
Net debt | (3,258) | (26,870) | (65,274) | ||||
| Cash flow | |||||||
Cash from operating activities | (14,154) | (16,949) | (8,049) | ||||
CAPEX | (8,222) | (192) | (19,015) | ||||
Cash from investing activities | (8,222) | (22,522) | (19,015) | ||||
Cash from financing activities | (1,183) | (1,275) | (808) | ||||
FCF | (9,569) | 7,496 | 2,398 | ||||
| Balance | |||||||
Cash | 5,258 | 28,619 | 69,732 | ||||
Long term investments | |||||||
Excess cash | 4,748 | 27,901 | 69,098 | ||||
Stockholders' equity | 765 | 765 | (37,210) | ||||
Invested Capital | 59,700 | 81,528 | 136,401 | ||||
ROIC | 6.76% | 1.70% | |||||
ROCE | 8.99% | 2.38% | |||||
| EV | |||||||
Common stock shares outstanding | 4,110 | 4,028 | 4,028 | ||||
Price | 1.79 -77.20% | 7.85 -41.42% | 13.40 -52.65% | ||||
Market cap | 7,357 -76.73% | 31,620 -41.42% | 53,976 -52.65% | ||||
EV | 4,099 | 4,750 | (11,297) | ||||
EBITDA | (5,129) | 11,434 | 6,103 | ||||
EV/EBITDA | 0.42 | ||||||
Interest | 447 | 353 | 297 | ||||
Interest/NOPBT | 4.77% | 12.57% | |||||